These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 29255353)
21. Vaccination of COPD patients with a pneumococcus type 6B tetanus toxoid conjugate vaccine. Jonsson S; Vidarsson G; Valdimarsson H; Schiffman G; Schneerson R; Jonsdottir I Eur Respir J; 2002 Oct; 20(4):813-8. PubMed ID: 12412669 [TBL] [Abstract][Full Text] [Related]
22. The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: Exploratory analysis of the CAPiTA trial. Huijts SM; Coenjaerts FEJ; Bolkenbaas M; van Werkhoven CH; Grobbee DE; Bonten MJM; Clin Microbiol Infect; 2018 Jul; 24(7):764-770. PubMed ID: 29050992 [TBL] [Abstract][Full Text] [Related]
23. Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease. Torres A; Blasi F; Dartois N; Akova M Thorax; 2015 Oct; 70(10):984-9. PubMed ID: 26219979 [TBL] [Abstract][Full Text] [Related]
24. Effects of 13-valent pneumococcal conjugate vaccination of adults on lower respiratory tract infections and antibiotic use in primary care: secondary analysis of a double-blind randomized placebo-controlled study. van Werkhoven CH; Bolkenbaas M; Huijts SM; Verheij TJM; Bonten MJM Clin Microbiol Infect; 2021 Jul; 27(7):995-999. PubMed ID: 32971253 [TBL] [Abstract][Full Text] [Related]
25. Compliance with influenza and pneumococcal vaccination among patients with chronic obstructive pulmonary disease consulting their medical practitioners in Catalonia, Spain. Jiménez-García R; Ariñez-Fernandez MC; Hernández-Barrera V; Garcia-Carballo MM; de Miguel AG; Carrasco-Garrido P J Infect; 2007 Jan; 54(1):65-74. PubMed ID: 17049991 [TBL] [Abstract][Full Text] [Related]
26. [Progress on the effectiveness of the pneumococcal vaccination in patients with chronic obstructive pulmonary disease]. Wu YX; Zhang J Zhonghua Jie He He Hu Xi Za Zhi; 2022 Apr; 45(4):404-409. PubMed ID: 35381638 [TBL] [Abstract][Full Text] [Related]
27. [Prevention of community-acquired pneumonia in adults]. Barros M M; Cartagena S C; Bavestrello F L Rev Chilena Infectol; 2005; 22 Suppl 1():s67-74. PubMed ID: 16163421 [TBL] [Abstract][Full Text] [Related]
28. Pneumococcal infections: association with asthma and COPD. Obert J; Burgel PR Med Mal Infect; 2012 May; 42(5):188-92. PubMed ID: 22444165 [TBL] [Abstract][Full Text] [Related]
29. Colonisation of Irish patients with chronic obstructive pulmonary disease by McCarthy H; Jackson M; Corcoran M; McElligott M; MacHale E; Sulaiman I; Cushen B; Costello RW; Humpreys H BMJ Open; 2017 Jul; 7(7):e013944. PubMed ID: 28694340 [TBL] [Abstract][Full Text] [Related]
30. Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study. Kondo K; Suzuki K; Washio M; Ohfuji S; Fukushima W; Maeda A; Hirota Y; Vaccine; 2017 Aug; 35(36):4806-4810. PubMed ID: 28818473 [TBL] [Abstract][Full Text] [Related]
31. Factors influencing acceptance of influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease. Saiphoklang N; Phadungwatthanachai J Hum Vaccin Immunother; 2022 Nov; 18(6):2102840. PubMed ID: 35943223 [TBL] [Abstract][Full Text] [Related]
32. [Reasons for adult immunization -- prevention of most frequent respiratory infections]. Ludwig E Orv Hetil; 2014 Nov; 155(44):1743-7. PubMed ID: 25344851 [TBL] [Abstract][Full Text] [Related]
33. Are younger COPD patients adequately vaccinated for influenza and pneumococcus? Gogou E; Hatzoglou C; Zarogiannis SG; Siachpazidou D; Gerogianni I; Kotsiou OS; Varsamas C; Gourgoulianis KI Respir Med; 2022 Nov; 203():106988. PubMed ID: 36162248 [TBL] [Abstract][Full Text] [Related]
34. Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States. Wiese AD; Griffin MR; Grijalva CG Expert Rev Vaccines; 2019 Apr; 18(4):327-341. PubMed ID: 30759352 [TBL] [Abstract][Full Text] [Related]
35. Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview. Vila-Corcoles A; Ochoa-Gondar O Expert Rev Vaccines; 2012 Feb; 11(2):221-36. PubMed ID: 22309670 [TBL] [Abstract][Full Text] [Related]
36. [Analysis of the clinical efficacy of vaccination against pneumococcal infection in patients with chronic obstructive pulmonary disease in combination with type 2 diabetes mellitus]. Ignatova GL; Blinova EV; Antonov VN Ter Arkh; 2022 Jan; 94(1):100-106. PubMed ID: 36286924 [TBL] [Abstract][Full Text] [Related]
37. Pneumococcal vaccine and patients with pulmonary diseases. Mirsaeidi M; Ebrahimi G; Allen MB; Aliberti S Am J Med; 2014 Sep; 127(9):886.e1-8. PubMed ID: 24852934 [TBL] [Abstract][Full Text] [Related]
38. [Vaccination against community acquired pneumonia in adult patients. A position paper by Neumoexpertos en Prevención]. Redondo E; Rivero I; Vargas DA; Mascarós E; Díaz-Maroto JL; Linares M; Valdepérez J; Gil A; Molina J; Jimeno I; Ocaña D; Martinón-Torres F; Semergen; 2016 Oct; 42(7):464-475. PubMed ID: 27641310 [TBL] [Abstract][Full Text] [Related]
39. Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adults. Isturiz R; Webber C Hum Vaccin Immunother; 2015; 11(7):1825-7. PubMed ID: 26076136 [TBL] [Abstract][Full Text] [Related]
40. [Impact of vaccination with pneumococcal vaccines on recurrent pneumonia in patients with chronic obstructive pulmonary disease]. Ignatova GL; Antonov VN Ter Arkh; 2022 Dec; 94(11):1257-1261. PubMed ID: 37167163 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]